专利检索 ap:"Raffaella Scorza" 第 1 页

1.

发明授权
Use of aminaphtone for the preparation of a medicament for treating arteriopathies 有权
标题翻译：氨基喋呤用于制备治疗动脉病的药物

公开(公告)号：US08202903B2

公开(公告)日：2012-06-19

申请号：US12296872

申请日：2007-04-10

申请人： Raffaella Scorza

发明人： Raffaella Scorza

IPC分类号： A61K31/21 , A01N37/12 , A01N57/00 , A01N43/42

CPC分类号： A61K31/245

摘要： The subject of the present invention is the use of aminaphtone for the preparation of a medicament for treating arteriophaties, in particular arteriophaties of a degenerative inflammatory type. Preferably, said medicament is formulated for oral administration.

摘要翻译： 本发明的主题是氨茶碱用于制备用于治疗动脉炎，特别是退行性炎症类型的动脉粥样硬化的药物的用途。优选地，将所述药物配制成口服给药。

2.

发明授权
Method of treating raynaud's disease secondary to connectivitis using aminaphtone 有权

公开(公告)号：US10028929B2

公开(公告)日：2018-07-24

申请号：US13005902

申请日：2011-01-13

申请人： Raffaella Scorza

发明人： Raffaella Scorza

IPC分类号： A61K31/245

摘要： The subject of the present invention is the use of aminaphtone for the preparation of a medicament for treating arteriophaties, in particular arteriophaties of a degenerative inflammatory type. Preferably, said medicament is formulated for oral administration.

3.

发明申请
USE OF AMINAPHTONE FOR THE PREPARATION OF A MEDICAMENT FOR TREATING ARTERIOPATHIES 有权
标题翻译：用于制备用于治疗异常性的药物的氨肽酶的用途

公开(公告)号：US20090182045A1

公开(公告)日：2009-07-16

申请号：US12296872

申请日：2007-04-10

申请人： Raffaella Scorza

发明人： Raffaella Scorza

IPC分类号： A61K31/216 , A61P3/10 , A61P9/10

CPC分类号： A61K31/245

摘要： The subject of the present invention is the use of aminaphtone for the preparation of a medicament for treating arteriophaties, in particular arteriophaties of a degenerative inflammatory type. Preferably, said medicament is formulated for oral administration.

摘要翻译： 本发明的主题是氨茶碱用于制备用于治疗动脉炎，特别是退行性炎症类型的动脉粥样硬化的药物的用途。优选地，将所述药物配制成口服给药。

4.

发明申请
IMMUNODIAGNOSTIC METHOD FOR DIAGNOSING AUTO-IMMUNE SYSTEMIC SCLEROSIS (SSC) AND SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) 审中-公开
标题翻译：用于诊断自身免疫系统性SCLEROSIS（SSC）和系统性红斑狼疮（SLE）的免疫组化方法

公开(公告)号：US20140080154A1

公开(公告)日：2014-03-20

申请号：US14007044

申请日：2012-04-13

申请人： Francesco Curcio , Giacomo Cattaruzzi , Massimo Moretti , Francesco Vitrani , Raffaella Scorza

发明人： Francesco Curcio , Giacomo Cattaruzzi , Massimo Moretti , Francesco Vitrani , Raffaella Scorza

IPC分类号： G01N33/569

CPC分类号： G01N33/56966 , G01N33/564 , G01N2800/101 , G01N2800/104

摘要： The invention relates to a method for the identification of patients affected by Systemic Sclerosis (SSc) (early, limited cutaneous, diffuse forms) or Systemic Lupus Erythematosus (SLE). Among SSc and SLE patients, this method allows identification of presence of vascular ulcerations in SSc, and Raynaud's phenomenon in SLE, respectively.

摘要翻译： 本发明涉及一种用于鉴定受系统性硬化症（SSc）（早期，有限皮肤，弥漫性形式）或系统性红斑狼疮（SLE）影响的患者的方法。在SSc和SLE患者中，该方法可以分别鉴定SSc中血管溃疡的存在和SLE中的雷诺现象。

5.

发明申请
USE OF AMINAPHTONE FOR THE PREPARATION OF A MEDICAMENT FOR TREATING ARTERIOPATHIES 审中-公开
标题翻译：用于制备用于治疗异常性的药物的氨肽酶的用途

公开(公告)号：US20120022155A1

公开(公告)日：2012-01-26

申请号：US13005902

申请日：2011-01-13

申请人： Raffaella SCORZA

发明人： Raffaella SCORZA

IPC分类号： A61K31/245 , A61P9/12 , A61P29/00 , A61P9/10

CPC分类号： A61K31/245

摘要： The subject of the present invention is the use of aminaphtone for the preparation of a medicament for treating arteriophaties, in particular arteriophaties of a degenerative inflammatory type. Preferably, said medicament is formulated for oral administration

摘要翻译： 本发明的主题是氨茶碱用于制备用于治疗动脉炎，特别是退行性炎症类型的动脉粥样硬化的药物的用途。优选地，将所述药物配制成口服给药